Good News Ventures

VC Toronto, Canada · Founded 2017

Good News Ventures invests in pre-seed and seed-stage technology startups with a strong focus on AI and Blockchain innovation. They back passionate founders who are not afraid to challenge the status quo and embrace risk, investing globally in B2B and B2B2C high-growth potential technology startups.

About Good News Ventures

Good News Ventures is an early-stage venture firm with a goodnewsventures.com website and LinkedIn and Twitter presence, with a generalist software thesis that the public footprint does not specifically tie to healthcare or AI sector focus. The naming suggests a positive-mission positioning. For healthcare AI founders, Good News is a peripheral fund best understood as potential syndicate capital rather than a thesis-aligned lead investor. Plausible check sizes for partnerships of this profile run 100K to 500K at seed and pre-seed, supporting rounds led by larger or more specialized firms. Founders building horizontal AI software with healthcare applications, healthcare-flavored consumer or B2B SaaS, or mission-aligned health businesses with strong commercial viability could open a conversation. Founders building regulated medical devices, therapeutics, or clinical AI requiring deep domain networks should look at healthcare-native firms. Entry path is LinkedIn direct outreach to partners with a tight pitch focused on team, traction, and market opportunity. Do not expect deep healthcare-specific diligence or sector value-add; expect a generalist read. Realistic triage: this is a name to keep on a closing list, not one to organize a round around. The signal-to-noise ratio of pursuing small generalist seed funds without published healthcare focus is poor; spend warm-introduction time on funds that bring something specific to the table, and only approach Good News once a thesis-aligned lead investor is committed. Treat any check from them as syndicate capital and avoid handing them governance influence given the absence of demonstrated healthcare expertise. The honest read is that founders should not invest meaningful pitch energy on funds whose public positioning does not establish healthcare conviction.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Other portfolio companies

Companies in Good News Ventures's portfolio not currently in our directory.

  • #paid
  • ACTO
  • Canaery
  • ChowNow
  • Coinchange
  • Dawrwin AI
  • Dashlabs
  • Datafold
  • DevCycle
  • Doorr
  • EAIGLE
  • Eleven-x

Team

Marat Mukhamedyarov
Managing Partner
LinkedIn
Mohan Markandaier
Managing Partner
LinkedIn
Ana Karina Riera
The Supporter

Pitch / review this investor

Have you raised from Good News Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.